Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Restless Legs Syndrome”

37 trials

Showing 20 of 37 results

Large-scale testing (Phase 3)Study completedNCT00390689
What this trial is testing

A Randomised, Comparing Fixed Doses of Pramipexole to Investigate the Efficacy and Safety in Patients With RLS.

Who this might be right for
Idiopathic Restless Legs Syndrome
Boehringer Ingelheim 154
Post-approval studies (Phase 4)Study completedNCT01823770
What this trial is testing

Effect of Rotigotine Patch Treatment on Cardiovascular Markers in Idiopathic Restless Legs Syndrome

Who this might be right for
Restless Legs Syndrome (RLS)
University Hospital, Montpellier 130
Testing effectiveness (Phase 2)Study completedNCT01562743
What this trial is testing

A Long-Term Extension Trial From Late Phase II of SPM 962 in Patients With Restless Legs Syndrome

Who this might be right for
Idiopathic Restless Legs Syndrome
Otsuka Pharmaceutical Co., Ltd. 185
Testing effectiveness (Phase 2)Study completedNCT00666965
What this trial is testing

A Placebo-Controlled Study for SPM 962 in Restless Legs Syndrome (RLS) Patients

Who this might be right for
Idiopathic Restless Legs Syndrome
Otsuka Pharmaceutical Co., Ltd. 230
Large-scale testing (Phase 3)Study completedNCT01112644
What this trial is testing

Oxycodone/Naloxone Prolonged Release (OXN PR) Compared to Placebo to Demonstrate Improvement in Symptoms of Restless Legs Syndrome (RLS) in Subjects With Moderate to Severe Idiopathic RLS With Daytime Symptoms

Who this might be right for
Moderate to Severe Idiopathic RLS With Daytime Symptoms
Mundipharma Research GmbH & Co KG 205
Large-scale testing (Phase 3)Study completedNCT00275236
What this trial is testing

A Sleep Lab Trial to Investigate the Efficacy and Safety of Transdermal Rotigotine in Subjects With Idiopathic Restless Legs Syndrome

Who this might be right for
Restless Legs Syndrome
UCB Pharma 60
Large-scale testing (Phase 3)Study completedNCT00263068
What this trial is testing

An Extension Trial to Investigate Long-Term Treatment With Transdermal Rotigotine in Idiopathic Restless Legs Syndrome

Who this might be right for
Restless Legs Syndrome
UCB Pharma 279
Testing effectiveness (Phase 2)Study completedNCT00389831
What this trial is testing

Efficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of RLS Symptoms

Who this might be right for
Restless Legs Syndrome
UCB Pharma 44
Testing effectiveness (Phase 2)Ended earlyNCT00834327
What this trial is testing

Efficacy and Safety Study of Aplindore in Patients With Restless Legs Syndrome

Who this might be right for
Restless Legs Syndrome
Neurogen Corporation 230
Large-scale testing (Phase 3)Study completedNCT00152958
What this trial is testing

A Study in Patients Suffering From Idiopathic Restless Legs Syndrome Who Responded to a Preceding, 6-month Treatment With Open-label Pramipexole Including Titration (0.125, 0.25, 0.5, 0.75 mg Orally q.n.)

Who this might be right for
Restless Legs Syndrome
Boehringer Ingelheim 224
Post-approval studies (Phase 4)Study completedNCT00356096
What this trial is testing

Phase IV Trial With Pramipexole to Evaluate Safety and Efficacy in Patients With RLS Associated With Mood Disturbances

Who this might be right for
Restless Legs SyndromeDepression
Boehringer Ingelheim 404
Not applicableStudy completedNCT04827329
What this trial is testing

Anesthetic Management of Patients With Chronic Sleep Disorders

Who this might be right for
NarcolepsyIdiopathic HypersomniaRestless Legs Syndrome
University Hospital, Montpellier 700
Large-scale testing (Phase 3)Study completedNCT00498108
What this trial is testing

Phase 3 Open-label Extension Trial With Rotigotine in Idiopathic Restless Legs Syndrome Subjects

Who this might be right for
Idiopathic Restless Legs Syndrome
UCB Pharma 341
Large-scale testing (Phase 3)Study completedNCT00136045
What this trial is testing

Three Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Leg Syndrome

Who this might be right for
Restless Legs Syndrome
UCB Pharma 549
Large-scale testing (Phase 3)Study completedNCT00133198
What this trial is testing

Efficacy and Safety of Pramipexole Compared to Placebo in the Treatment of Restless Legs Syndrome (RLS)

Who this might be right for
Restless Legs Syndrome
Boehringer Ingelheim 345
Large-scale testing (Phase 3)Study completedNCT00135993
What this trial is testing

Four Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Legs Syndrome

Who this might be right for
Restless Legs Syndrome
UCB Pharma 811
Large-scale testing (Phase 3)Study completedNCT00275457
What this trial is testing

Efficacy and Safety of Pramipexole (PPX) in Moderate to Severe Idiopathic Restless Legs Syndrome (RLS) Patients

Who this might be right for
Restless Legs Syndrome
Boehringer Ingelheim 346
Large-scale testing (Phase 3)Study completedNCT00806026
What this trial is testing

Long Term Study Of Pregabalin In Idiopathic Restless Legs Syndrome Patients

Who this might be right for
Idiopathic Restless Legs Syndrome
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 731
Post-approval studies (Phase 4)Study completedNCT00472199
What this trial is testing

Long-term Efficacy, Safety and Tolerability of Pramipexole in Patients With Idiopathic Moderate to Severe Restless Legs Syndrome (RLS)

Who this might be right for
Restless Legs Syndrome
Boehringer Ingelheim 331
Large-scale testing (Phase 3)Study completedNCT00654498
What this trial is testing

Pramipexole in Out-patients With Idiopathic Restless Legs Syndrome (IRLS)

Who this might be right for
Restless Legs Syndrome
Boehringer Ingelheim 306
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation